Levetiracetam Desitin

Levetiracetam, the active ingredient in Levetiracetam Desitin, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of epilepsy, including partial seizures and generalized tonic‑clonic seizures, in both adult and pediatric patients.

GNH USA supplies Levetiracetam Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution for this essential seizure‑control medication.

Levetiracetam is used in the management of epilepsy and related seizure disorders.

- Partial seizures: reduces the frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Epilepsy (broad): provides overall seizure reduction across multiple seizure types. - Adjunct therapy: can be combined with other antiepileptic drugs to improve overall seizure control.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Mood alterations including depression or suicidal thoughts - Blood dyscrasias such as agranulocytosis - Respiratory depression (rare) - Severe skin reactions (e.g., drug rash with eosinophilia and systemic symptoms)

Before initiating therapy, clinicians should consider several safety factors.

- Renal impairment: dose adjustment may be required based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests and adjust dosing if necessary. - Psychiatric history: observe for mood changes, depression, or suicidal ideation. - Concomitant CNS depressants: may increase sedation; use with caution. - Pregnancy: risk unknown; discuss potential benefits and risks with a healthcare professional. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam levels. - Phenobarbital: may decrease levetiracetam exposure. - Rifampin: induces metabolism leading to reduced efficacy.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Benzodiazepines or other CNS depressants: increased sedation risk. - Selective serotonin reuptake inhibitors (SSRIs): monitor for mood changes. - Immunosuppressants (e.g., tacrolimus): may require therapeutic drug monitoring.